AEQUITA PHARMACY recalls Tirzepat: 6.6 mg + 1.0mg/0.5 mL injectable solution due to lack of processing controls. No remedy specified in official notice.
Lack of Processing Controls.
AEQUITA PHARMACY is recalling a specific injectable medication combination for potential quality issues. This recall does not include a remedy or action for consumers.
The product was manufactured without proper processing controls, which could lead to quality issues. However, the exact hazard mechanism is not clearly described in the recall notice.
People who have purchased or received this specific injectable medication combination from AEQUITA PHARMACY. Those with diabetes or other conditions requiring this medication are most at risk.
Check for the product name: Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial. All lots within expiry date.
Identify the product by its specific name and packaging as listed in the recall notice.
The official notice does not specify any remedy.
The recall states there was a lack of processing controls, but does not clearly describe the specific hazard.
Look for the product name: Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial. All lots within expiry.
We’ve drafted a message you can send AEQUITA PHARMACY to request your refund or repair — edit it as you like.
Subject: Recall D-0556-2025 — AEQUITA PHARMACY AEQUITA PHARMACY Hello, I own a AEQUITA PHARMACY that is covered by recall D-0556-2025 from AEQUITA PHARMACY. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
